Clinical Trials Logo
  1. Home
  2. Cystitis
  3. NCT00957333
  4. Details
NCT00957333 Clinical Trial

Effects of Ketamine on Human Bladders and Its Possible Mechanisms

Cystitis Clinical Trial

Official title:
Effects of Ketamine on Human Bladders and Its Possible Mechanisms

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00957333
Other study ID # DOH98-NNB-1049
Secondary ID
Status Completed
Phase N/A
First received August 3, 2009
Last updated December 8, 2015
Start date March 2009
Est. completion date December 2011

Study information
Verified date November 2010
Source Taipei Medical University WanFang Hospital
Contact n/a
Is FDA regulated No
Health authority Taiwan: Department of Health
Study type Observational

Clinical Trial Summary

This study is aimed to evaluate the relationship between ketamine abused and bladder dysfunction and its possible mechanisms.

Recruitment information / eligibility
Status Completed
Enrollment 44
Est. completion date December 2011
Est. primary completion date December 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adult male or female

- Cystitis (the clinicians ruled out the causes of bacterial infection)

- Frequent micturition

- The clinicians are willing to sign the ICF

Exclusion Criteria:

- Suffers from the urinary system disease, is not suitable to carry on the urinary bladder biopsy sampling

- Suffers from other diseases, doctor recognized that is not suitable to carry on the sampling

- The clinicians are not willing to sign the ICF

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

Intervention

Other:
• ketamine
N.A.

Locations
Country Name City State
Taiwan Taipei Medical University-Wan Fang Hospital Taipei

Sponsors (1)
Lead Sponsor Collaborator
Taipei Medical University WanFang Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Substance Abuse Situation Record Substance abuse situation record: ketamine 1 day No
Secondary Urinary Bladder Capacity 1 day No
See also
  Status Clinical Trial Phase
Withdrawn NCT00361998 - Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis Phase 4
Completed NCT03275623 - Management of Sub-Clinical Bacteriuria in Pregnancy Phase 4
Not yet recruiting NCT05055544 - Bearberry in the Treatment of Cystitis N/A
Active, not recruiting NCT01966653 - Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women Phase 4
Withdrawn NCT01527019 - Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI) Phase 3
Completed NCT03877289 - Efficacy of Oxybutynin in Paediatric Cystitis Phase 4
Completed NCT05584657 - Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women Phase 3
Terminated NCT00164099 - The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study Phase 4
Completed NCT00528476 - Risk Factors for Recurrent Urinary Tract Infection in Children N/A
Completed NCT04987164 - Incidence of Cystitis in Women Consuming a Mixture of Cranberry, Cinnamon, Probiotics
Completed NCT01861353 - Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children N/A
Completed NCT05945667 - Efficacy and Safety of Uronext® in Women With Cystitis N/A
Recruiting NCT05360914 - Hospital at Home for Elderly Acute Ill Patients N/A
Completed NCT04272281 - Use of a Share Decision Making Tool in the Care of Acute Cystitis Without Risk of Complication in Primary Care N/A
Completed NCT03425396 - Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis Phase 2
Completed NCT05260554 - Effect of Cranberry Extract on the Urinary System
Unknown status NCT00622076 - Postoperative Catheterization After Anterior Colporrhaphy N/A
Completed NCT00801021 - Treatment and/or Prevention of Urinary Tract Infections Phase 1
Terminated NCT01060254 - A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain Phase 2
Not yet recruiting NCT06391164 - Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis Phase 2